GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

ELAN · Sep 30, 2021

Elanco Animal Health Inc. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001739104-21-000017General Corporate
Debt relative to revenue92thOwn-history percentile · N=12
Evidence method

Level · gp.fundamentals.debt_to_revenue

560.04% · OPTIONAL · VALID

Capex intensity33thOwn-history percentile · N=9
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

2.21% · OPTIONAL · VALID

Operating cash generation73thOwn-history percentile · N=11
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

7.87% · OPTIONAL · VALID

Revenue growth75thOwn-history percentile · N=8
Evidence method

Yoy · gp.fundamentals.revenue

27.14% · CORE · VALID

Inventory pressure42thOwn-history percentile · N=12
Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

122.28% · OPTIONAL · VALID

Gross margin92thOwn-history percentile · N=12
Evidence method

Level · gp.fundamentals.gross_margin

55.61% · CORE · VALID

R&D intensity33thOwn-history percentile · N=12
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

8.31% · OPTIONAL · VALID

SBC intensity64thOwn-history percentile · N=11
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

1.50% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History28 statesSelf-history eligible
Sep 30, 20218/8 normalizedLevel 3Dec 31, 20218/8 normalizedLevel 3Mar 31, 20228/8 normalizedLevel 3Jun 30, 20228/8 normalizedLevel 3Sep 30, 20228/8 normalizedLevel 3Dec 31, 20228/8 normalizedLevel 3Mar 31, 20238/8 normalizedLevel 3Jun 30, 20237/7 normalizedLevel 3Sep 30, 20237/7 normalizedLevel 3Dec 31, 20238/8 normalizedLevel 3Mar 31, 20248/8 normalizedLevel 3Jun 30, 20248/8 normalizedLevel 3Sep 30, 20248/8 normalizedLevel 3Dec 31, 20248/8 normalizedLevel 3Mar 31, 20258/8 normalizedLevel 3Jun 30, 20258/8 normalizedLevel 3Sep 30, 20258/8 normalizedLevel 3Dec 31, 20258/8 normalizedLevel 3Mar 31, 20268/8 normalizedLevel 3Jun 30, 20268/8 normalizedLevel 4
Period transition

What moved in the state?

Balance Sheet Leverage Increased
Previous
476.70%
Current
560.04%
Delta
83.33%
Capex Intensity Increased
Previous
1.33%
Current
2.21%
Delta
0.88%
Cash Generation Decreased
Previous
11.65%
Current
7.87%
Delta
-3.78%
Growth Decreased
Previous
118.15%
Current
27.14%
Delta
-91.01%
Inventory Pressure Increased
Previous
113.37%
Current
122.28%
Delta
8.91%
Margin Decreased
Previous
56.92%
Current
55.61%
Delta
-1.30%
R And D Intensity Increased
Previous
7.35%
Current
8.31%
Delta
0.96%
Sbc Intensity Increased
Previous
1.25%
Current
1.50%
Delta
0.25%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Transitioned To · ELAN Fundamental State →Has State · Elanco Animal Health Inc →Transitioned To · ELAN Fundamental State →Transitioned To · ELAN BALANCE_SHEET_LEVERAGE_INCREASED →Transitioned To · ELAN CAPEX_INTENSITY_INCREASED →Transitioned To · ELAN CASH_GENERATION_DECREASED →Transitioned To · ELAN GROWTH_DECREASED →Transitioned To · ELAN INVENTORY_PRESSURE_INCREASED →Transitioned To · ELAN MARGIN_DECREASED →Transitioned To · ELAN R_AND_D_INTENSITY_INCREASED →Transitioned To · ELAN SBC_INTENSITY_INCREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.